March 27, 2023, Vancouver, British Columbia: Gemina Laboratories Ltd. (CSE: GLAB) (FRA:8I7) (the “Company” or “Gemina”) is pleased to announce that it will host a live investor webinar presentation on Thursday, March 30, 2023, at 2:00 PM ET. During the webcast, Brian Firth, CEO, will conduct a presentation that will cover key areas of Gemina’s business. After the formal presentation, participants will have the opportunity to ask questions through an interactive Q&A portal. To listen to the webcast or to ask questions during the live event, please pre-register by clicking on the following link:
Registration Link: Gemina Webinar Registration
An archived version of the webcast and presentation will be available on the Company’s website following the live event: www.geminalabs.com/investors.
On Behalf of the Board of Directors,
John Davies, Chairman Gemina Laboratories Ltd.
About Gemina Laboratories Ltd.
Gemina Labs is a biosensor and diagnostic company with a transformative, patented, proprietary chemistry technology platform that powers next-generation testing platforms for a wide range of pathogens that affect human health and wellness. Our technologies drive testing platforms that are fast, affordable, accurate, and easily self-administered. Our own product pipeline includes platforms for the rapid testing of COVID-19, influenza, tuberculosis and other viruses. Additional information on the Company can be found at www.geminalabs.com.